Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma

Haematologica. 2016 Mar;101(3):e116-9. doi: 10.3324/haematol.2015.136929. Epub 2015 Nov 26.

¹ Department of Internal Medicine V, University of Heidelberg, Germany Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA NWeinhold@uams.edu.
² Institute of Human Genetics, University of Heidelberg, Germany.
³ Department of Internal Medicine V, University of Heidelberg, Germany.
⁴ Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
⁵ Department of Hematology and Oncology, Asklepios Klinik Altona, Hamburg, Germany.
⁶ Department of Medicine III, Charité Campus Benjamin Franklin, Berlin, Germany.
⁷ Department of Hematology, Oncology and Immunology, University of Tübingen, Germany.
⁸ Department of Internal Medicine V, University of Heidelberg, Germany National Center for Tumor Diseases, Heidelberg, Germany.

No abstract available

Keywords: MYC rearrangements; cytogenetics and molecular genetics; multiple myeloma; outcome.

Publication types